214 related articles for article (PubMed ID: 61185)
21. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Boon TA
Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
[TBL] [Abstract][Full Text] [Related]
22. [Incidence of the form and caliber of urethral resistance. Evaluation for a normal masculine urethra and in cases of obstruction due to prostatic hypertrophy].
Glémain P; Cordonnier JP; Bochereau G; Baron M; Le Normand L; Buzelin JM
Prog Urol; 1993 Dec; 3(6):995-1015; discussion 1006-8. PubMed ID: 7508314
[TBL] [Abstract][Full Text] [Related]
23. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
[TBL] [Abstract][Full Text] [Related]
24. Effect of catheter size on urodynamic assessment of bladder outlet obstruction.
Klausner AP; Galea J; Vapnek JM
Urology; 2002 Nov; 60(5):875-80. PubMed ID: 12429319
[TBL] [Abstract][Full Text] [Related]
25. The obstructive effect of a urethral catheter.
Reynard JM; Lim C; Swami S; Abrams P
J Urol; 1996 Mar; 155(3):901-3. PubMed ID: 8583602
[TBL] [Abstract][Full Text] [Related]
26. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement.
Witjes WP; de Wildt MJ; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
J Urol; 1996 Sep; 156(3):1026-34. PubMed ID: 8709301
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia].
Wu Z; Wu K; Wang B
Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477
[TBL] [Abstract][Full Text] [Related]
28. [A self-retaining intraurethral device as an alternative to indwelling catheter and prostatectomy].
Nissenkorn I; Aronheim M; Sluzker D; Richter S
Harefuah; 1990 Nov; 119(9):254-6. PubMed ID: 1701751
[TBL] [Abstract][Full Text] [Related]
29. Urodynamics in benign prostatic hypertrophy.
Anikwe RM
Br J Urol; 1978 Feb; 50(1):20-4. PubMed ID: 75752
[TBL] [Abstract][Full Text] [Related]
30. Role of UPP in evaluating bladder outlet obstruction due to benign prostatic enlargement.
Fang Q; Song B; Li W; Lu G; Jin X; Zhang X; Fan R
Neurourol Urodyn; 2007; 26(6):842-6. PubMed ID: 17565728
[TBL] [Abstract][Full Text] [Related]
31. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
Zhang P; Wu ZJ; Yang Y; Zhang XD
Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
33. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
34. [Transurethral prostatic thermotherapy with microwaves (prostatron system) in bladder obstruction secondary to benign prostatic hypertrophy].
Mompó Sanchis JA; Paya Navarro JJ; Prosper Rovira F
Arch Esp Urol; 1994 Jun; 47(5):461-71. PubMed ID: 7524453
[TBL] [Abstract][Full Text] [Related]
35. [Study on voiding disturbance in elderly males. II. Analysis of the patterns in uroflowmetric studies in patients with obstructive diseases in lower urinary tract and neurogenic bladder].
Shimizu K; Takahashi Y; Nakai K; Imai K; Yamanaka H; Mayuzumi T; Sato Z
Hinyokika Kiyo; 1985 Sep; 31(9):1575-81. PubMed ID: 2417465
[TBL] [Abstract][Full Text] [Related]
36. Benign prostatic hypertrophy.
O'Brien WM
Am Fam Physician; 1991 Jul; 44(1):162-71. PubMed ID: 1711771
[TBL] [Abstract][Full Text] [Related]
37. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement.
Rosier PF; de la Rosette JJ; de Wildt MJ; Debruyne FM; Wijkstra H
Neurourol Urodyn; 1996; 15(1):1-10; discussion 10-5. PubMed ID: 8696351
[TBL] [Abstract][Full Text] [Related]
38. A mathematical micturition model to restore simple flow recordings in healthy and symptomatic individuals and enhance uroflow interpretation.
Valentini FA; Besson GR; Nelson PP; Zimmern PE
Neurourol Urodyn; 2000; 19(2):153-76. PubMed ID: 10679832
[TBL] [Abstract][Full Text] [Related]
39. Management of benign prostatic hypertrophy-related urinary retention: current trends and perspectives.
Stamatiou K
Urol J; 2009; 6(4):237-44. PubMed ID: 20027550
[TBL] [Abstract][Full Text] [Related]
40. Influence of catheter on urinary flow during urodynamic pressure-flow study in men with symptomatic benign prostatic hyperplasia.
Trumbeckas D; Milonas D; Jievaltas M; Danilevicius M; Matjosaitis AJ
Medicina (Kaunas); 2006; 42(1):15-21. PubMed ID: 16467609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
